Importance of prognostic factors in the treatment of CLL and how to assess them
Drug combinations in CLL: ibrutinib, idelalisib and more
How does the quality of life of a CLL patient change with ongoing treatment?
CLL highlights from ASCO 2016: HELIOS trial, CAR T-cell therapy and CLL-IPI
The 20th anniversary of the German CLL Study Group and the importance of collaboration